Trial Profile
Ginkgo biloba prevention trial in older individuals
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2016
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- Acronyms GEM
- 01 Nov 2010 Planned end date changed from 1 Jul 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 01 Nov 2010 Planned end date changed from 1 Jul 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 23 Dec 2009 Primary endpoint results published in the JAMA: the Journal of the American Medical Association 302: 2663-70, No. 24, 23 Dec 2009